Dr. Arcenas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
50 Irving St Nw
Washington, DC 20422Phone+1 202-745-4058Fax+1 202-745-8131
Education & Training
- University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1991 - 1993
- Wayne State University School of MedicineResidency, Internal Medicine, 1988 - 1991
- SUNY Upstate Medical UniversityInternship, Transitional Year, 1987 - 1988
- University of the Philippines College of MedicineClass of 1985
Certifications & Licensure
- TX State Medical License 1992 - 2024
- DC State Medical License 1993 - 2022
Clinical Trials
Publications & Presentations
PubMed
- 48 citationsIntravenous Zoledronic Acid to Prevent Osteoporosis in a Veteran Population With Multiple Risk Factors for Bone Loss on Androgen Deprivation TherapyNirmala Bhoopalam, Steven C. Campbell, Thomas E. Moritz, William R. Broderick, Padmini Iyer
The Journal of Urology. 2009-11-01 - 224 citationsTirapazamine Plus Cisplatin Versus Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Report of the International CATAPULT I Study GroupJ. von Pawel, R. von Roemeling, U. Gatzemeier, Michael Boyer, L O Elisson
Journal of Clinical Oncology. 2000-03-13 - 40 citationsEffects of PIXY321, a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein, on chemotherapy-induced multilineage myelosuppression in patients ...Saroj Vadhan-Raj, Nicholas E. Papadopoulos, Michael A. Burgess, Kaye A. Linke, Shreyaskumar Patel
Journal of Clinical Oncology. 1994-04-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: